IXOPAY nomme Brady Harris au poste de PDG en vue de stimuler le développement de ses solutions de paiement à l’échelle mondiale

À la suite de la fusion entre IXOPAY et TokenEx, la nouvelle direction renforce la position de l’entreprise sur le marché pour répondre aux besoins en perpétuelle évolution de ses clients

TULSA, État d’Oklahoma, 03 juin 2024 (GLOBE NEWSWIRE) — IXOPAY annonce accueillir ce jour l’éminent et très expérimenté Brady Harris au poste de PDG. Cette nomination coïncide avec la récente fusion entre IXOPAY et TokenEx, et marque une nette transition dans le secteur des paiements. Cette évolution repose sur une approche multi-processeurs permettant aux commerçants et aux acteurs de la fintech de relever et diversifier leurs stratégies de paiement. L’entreprise adresse ses remerciements au PDG sortant, Marc Olesen, pour sa direction et toutes ses contributions.

Selon Glassdoor, Monsieur Harris se distingue parmi les trois meilleurs PDG des États-Unis. Il apporte plus de 20 ans d’expérience et de leadership de direction dans les domaines de la fintech, des paiements et des solutions SaaS. Alors PDG de Dwolla, il a piloté l’essor des volumes de paiements annuels, les faisant passer de 10 milliards à 70 milliards de dollars, tout en enregistrant 1,5 million de nouveaux utilisateurs chaque mois. Avant de rejoindre Dwolla, il a présidé Payscape, et son rôle s’est avéré déterminant dans sa fusion avec Payroc, qui a donné naissance à un fournisseur de services de paiement d’envergure mondiale employant plus de 1 000 collaborateurs au sein de 13 bureaux répartis travers le monde. En unissant leurs forces, ces deux entreprises ont mis au monde une structure opérationnelle au service de 150 000 sociétés dans 46 pays.

À l’heure où IXOPAY cherche ses marques pour se positionner en tant que fournisseur d’une solution tout-en-un sur le marché des solutions de paiement, l’expertise de Brady Harris en matière de fusions et acquisitions et de développement d’entreprises jusqu’à les faire sortir avec succès de la tutelle de leurs sponsors en capital-investissement s’avère fondamentale. La fusion entre IXOPAY et TokenEx a donné le jour à une plateforme capable de proposer à la fois une tokenisation omnicanale et une synchronisation des paiements, mais aussi une gestion du cycle de vie des cartes. Cette fusion répond aux exigences de prolixité, d’expansion géographique et de capacités de négociation des frais, inexistantes du côté des systèmes à processeur unique.

Pour Monsieur Harris, « La technologie applicable aux paiements évolue rapidement, et IXOPAY entend servir de locomotive dans ce parcours. L’intégration de la tokenisation et de la synchronisation nous permet de proposer une plateforme qui, au-delà de prendre en charge le traitement multi-paiements, favorise également le développement de nouveaux services. »

« Sous la direction de Brady, IXOPAY est à même d’établir de nouveaux standards applicables au secteur des paiements », remarque Vik Verma, président du conseil d’administration. Et d’ajouter : « Notre ambitieuse stratégie se focalise sur la mise à l’échelle, la sécurité et les avancées révolutionnaires qui redessineront les contours de ce que les paiements peuvent atteindre. »

Monsieur Harris et l’équipe d’IXOPAY participent à l’événement Money 20/20 organisé cette semaine à Amsterdam. Ensemble, ils auront l’occasion de présenter les offres complémentaires issues de la fusion, notamment les avancées en matière de synchronisation des paiements, de tokenisation, de gestion des risques et de gestion du cycle de vie des cartes. Nous vous invitons à les rejoindre au stand 8a202 du complexe RAI d’Amsterdam pour découvrir comment les développements évoqués dans le présent communiqué façonneront l’avenir des paiements pour les commerçants.

Pour tout complément d’information, veuillez contacter :
Nicholas Mueller
Vice-président directeur du Marketing
[email protected]

À propos d’IXOPAY
IXOPAY, une société du groupe TokenEx, est l’opérateur d’une plateforme indépendante et flexible dédiée à la synchronisation des paiements, assurant la gestion de tous les services de paiement sous un seul toit. À la suite de sa récente fusion avec TokenEx, IXOPAY est en mesure de développer ses services à l’échelle mondiale en proposant des capacités améliorées en matière de traitement des paiements, mais aussi des protocoles de sécurité avancés.

Une photo accompagnant le présent communiqué est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/2750a812-2a7a-420b-82b4-614b2f1eeb5c

GlobeNewswire Distribution ID 9147996

Nyxoah to Participate in the Jefferies Global Healthcare Conference

Mont-Saint-Guibert, Belgium – June 3, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Jefferies Global Healthcare Conference, which takes place June 5 – 6, 2024 in New York.

Olivier Taelman, Nyxoah’s Chief Executive Officer, will deliver a corporate presentation on Wednesday, June 5, 2024, at 7:30am ET. A webcast of the presentation will be available in the Events section of Nyxoah’s Investor Relations website. The Company will be available for 1×1 meetings with institutional investors.

Nyxoah’s Investor Presentation can be accessed on the Shareholder Information section of the Company’s Investor Relations page.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward-looking statements
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contact:
Nyxoah
David DeMartino, Chief Strategy Officer
[email protected]

Attachment

GlobeNewswire Distribution ID 1000964374

Information on the total number of voting rights and shares

REGULATED INFORMATION

Information on the total number of voting rights and shares

Mont-Saint-Guibert (Belgium), June 3, 2024, 10:15 pm CET / 4:15 pm ET –In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.

  •  Share capital: EUR 5,902,793.43
  •  Total number of securities carrying voting rights: 34,360,390 (all ordinary shares)
  •  Total number of voting rights (= denominator): 34,360,390 (all relating to ordinary shares)
  •  Number of rights to subscribe to securities carrying voting rights not yet issued:
    •  100 “2018 ESOP Warrants” issued on December 12, 2018, entitling their holders to subscribe to a total number of 50,000 securities carrying voting rights (all ordinary shares);
    •  400,500 “2020 ESOP Warrants” issued on February 21, 2020, entitling their holders to subscribe to a total number of 400,500 securities carrying voting rights (all ordinary shares); and
    •  1,070,500 “2021 ESOP Warrants” issued on September 8, 2021, entitling their holders to subscribe to a total number of 1,070,500 securities carrying voting rights (all ordinary shares); and
    •  700,000 “2022 ESOP Warrants” issued on December 28, 2022, entitling their holders to subscribe to a total number of 700,000 securities carrying voting rights (all ordinary shares).

Contact:
Nyxoah
David DeMartino, Chief Strategy Officer
[email protected]

Attachment

GlobeNewswire Distribution ID 1000964376

Publication relating to transparency notifications

REGULATED INFORMATION

Publication relating to transparency notifications

Mont-Saint-Guibert (Belgium), June 3, 2024, 10.05pm CET / 4.05pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received four transparency notifications as detailed below.

FMR LLC

On May 30, 2024, Nyxoah received a transparency notification from FMR LLC following the crossing above the 3% threshold on May 28, 2024. As of such date, FMR LLC (together with its controlled undertakings) held 1,698,402 voting rights, consisting of 1,613,888 shares and 84,514 equivalent financial instruments, representing 4.99% of the total number of voting rights on May 28, 2024 (34,060,390).

The notification dated May 30, 2024 contains the following information:

    •  Reason for the notification: acquisition or disposal of voting securities or voting rights
    •  Notification by: a parent undertaking or a controlling person
    •  Persons subject to the notification requirement: FMR LLC (with address at The Corporation Trust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware, 19801, U.S.A.)
    •  Date on which the threshold was crossed: May 28, 2024
    •  Threshold that is crossed: 3%
    •  Denominator: 34,060,390
    •  Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the securities Linked to securities Not linked to the securities
FMR LLC 0 0 0.00%
FIAM LLC 0 258 0.00%
Fidelity Management & Research Company LLC 0 1,613,630 4.74%
Subtotal   1,613,888   4.74%  
TOTAL 1,613,888 0 4.74% 0.00%
B) Equivalent financial instruments After the transaction
Holders of equivalent financial instruments Type of financial instrument Expiration date Exercise period or date # of voting rights that may be acquired if the instrument is exercised % of voting rights Settlement
Fidelity Management & Research Company LLC Stock Loan 84,514 0.25% physical
TOTAL     84,514 0.25%  
TOTAL (A & B) # of voting rights % of voting rights  
      1,698,402 4.99%  
    •  Full chain of controlled undertakings through which the holding is effectively held: FIAM LLC is controlled by FIAM Holdings LLC. FIAM Holdings LLC, Fidelity Management & Research Company LLC are controlled by FMR LLC. FMR LLC is not a controlled undertaking.
    •  Additional information: The holdings attributed to the entities mentioned above arise from holdings of various undertakings for collective investment that are managed by FIAM LLC, Fidelity Management & Research Company LLC, each of which are entities that are subsidiaries of and controlled by FMR LLC. The entities mentioned above are the discretionary investment managers and exercise the voting rights at their discretion in the absence of specific instructions.

BlackRock, Inc.

On June 3, 2024, Nyxoah received a transparency notification from BlackRock, Inc. following the crossing above the 3% threshold on May 28, 2024. As of such date, BlackRock, Inc. (together with its controlled undertakings) held 1,116,429 voting rights, consisting of 1,097,929 shares and 18,500 equivalent financial instruments, representing 3.28% of the total number of voting rights on May 28, 2024 (34,060,390).

The notification dated May 29, 2024 contains the following information:

    •  Reason for the notification: acquisition or disposal of voting securities or voting rights
    •  Notification by: a parent undertaking or a controlling person
    •  Persons subject to the notification requirement:
      •  BlackRock, Inc. (with address at 50 Hudson Yards, New York, NY, 10001, U.S.A.)
      •  BlackRock Advisors, LLC (with address at 50 Hudson Yards, New York, NY, 10001, U.S.A.)
      •  BlackRock Fund Advisors (with address at 400 Howard Street, San Francisco, CA, 94105, U.S.A.)
      •  BlackRock Investment Management (UK) Limited (with address at 12 Throgmorton Avenue, London, EC2N 2DL, U.K.)
      •  BlackRock Investment Management, LLC (with address at 1 University Square Drive, Princeton, NJ, 8540, U.S.A.)
    •  Date on which the threshold was crossed: May 28, 2024
    •  Threshold that is crossed: 3%
    •  Denominator: 34,060,390
    •  Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the securities Linked to securities Not linked to the securities
BlackRock, Inc. 0 0.00%
BlackRock Advisors, LLC 1,071,561 3.15%
BlackRock Fund Advisors 46 0.00%
BlackRock Investment Management (UK) Limited 1,080 0.00%
BlackRock Investment Management, LLC 25,242 0.07%
Subtotal   1,097,929   3.22%  
TOTAL 1,097,929 0 3.22% 0.00%
B) Equivalent financial instruments After the transaction
Holders of equivalent financial instruments Type of financial instrument Expiration date Exercise period or date # of voting rights that may be acquired if the instrument is exercised % of voting rights Settlement
BlackRock Advisors, LLC Securities Lent 17,600 0.05% physical
BlackRock Fund Advisors Securities Lent 900 0.00% physical
TOTAL     18,500 0.05%  
TOTAL (A & B) # of voting rights % of voting rights  
      1,116,429 3.28%  
    •  Full chain of controlled undertakings through which the holding is effectively held:

BlackRock, Inc.
Trident Merger, LLC
BlackRock Investment Management, LLC

BlackRock, Inc.
BlackRock Holdco 2, Inc.
BlackRock Financial Management, Inc.
BlackRock International Holdings, Inc.
BR Jersey International Holdings L.P.
BlackRock Holdco 3, LLC
BlackRock Cayman 1 LP
BlackRock Cayman West Bay Finco Limited
BlackRock Cayman West Bay IV Limited
BlackRock Group Limited
BlackRock Finance Europe Limited
BlackRock Investment Management (UK) Limited

BlackRock, Inc.
BlackRock Holdco 2, Inc.
BlackRock Financial Management, Inc.
BlackRock Holdco 4, LLC
BlackRock Holdco 6, LLC
BlackRock Delaware Holdings Inc.
BlackRock Fund Advisors

BlackRock, Inc.
BlackRock Holdco 2, Inc.
BlackRock Financial Management, Inc.
BlackRock Capital Holdings, Inc.
BlackRock Advisors, LLC

    •  Additional information: The disclosure obligation arose due to voting rights attached to shares for BlackRock, Inc. going above 3%. Additionally, total holdings for BlackRock, Inc. went above 3%. The disclosure obligation arose due to voting rights attached to shares for BlackRock Advisors, LLC going above 3%. Additionally, total holdings for BlackRock Advisors, LLC went above 3%.

Together Partnership

On June 3, 2024, Nyxoah received a transparency notification from Together Partnership following the passive crossing below the 10% threshold on May 28, 2024. As of such date, Together Partnership held 2,940,258 shares, representing 8.63% of the total number of voting rights on May 28, 2024 (34,060,390).

The notification dated June 3, 2024 contains the following information:

    •  Reason for the notification: passive crossing of a threshold
    •  Notification by: a person that notifies alone
    •  Persons subject to the notification requirement: Together Partnership (with address at Van Putlei 31, 2018 Antwerp, Belgium)
    •  Date on which the threshold was crossed: May 28, 2024
    •  Threshold that is crossed: 10%
    •  Denominator: 34,060,390
    •  Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the securities Linked to securities Not linked to the securities
Together Partnership 2,948,285 2,940,258 8.63%
TOTAL 2,940,258 0 8.63% 0.00%
    •  Full chain of controlled undertakings through which the holding is effectively held: Together Partnership is not a controlled entity.

Gilde Healthcare Holding BV and Gilde Healthcare III Management BV

On May 31, 2024, Nyxoah received a transparency notification from Gilde Healthcare Holding BV and Gilde Healthcare III Management BV following the passive crossing below the 10% threshold on May 28, 2024. As of such date, Gilde Healthcare Holding BV and Gilde Healthcare III Management BV (together with their controlled undertakings) held 2,936,890 shares, representing 8.62% of the total number of voting rights on May 28, 2024 (34,060,390).

The notification dated May 31, 2024 contains the following information:

    •  Reason for the notification: passive crossing of a threshold
    •  Notification by: a parent undertaking or a controlling person
    •  Persons subject to the notification requirement:
      •  Gilde Healthcare Holding BV (with address at Stadsplateau 36, 3521 AZ Utrecht, the Netherlands)
      •  Gilde Healthcare III Management BV (with address at Stadsplateau 36, 3521 AZ Utrecht, the Netherlands)
    •  Date on which the threshold was crossed: May 28, 2024
    •  Threshold that is crossed: 10%
    •  Denominator: 34,060,390
    •  Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the securities Linked to securities Not linked to the securities
Gilde Healthcare Holding BV 0 0 0.00%
Gilde Healthcare III Management BV 3,153,822 2,936,890 8.62%
Subtotal 3,153,822 2,936,890   8.62%  
TOTAL 2,936,890 0 8.62% 0.00%
    •  Full chain of controlled undertakings through which the holding is effectively held: Gilde Healthcare III Management BV is controlled by Gilde Healthcare Holding BV. Gilde Healthcare Holding BV is not a controlled entity.
    •  Additional information: Cooperatieve Gilde Healthcare III Sub-Holding UA and Cooperatieve Gilde Healthcare III Sub-Holding 2 UA hold the shares in Nyxoah. Gilde Healthcare III Management BV is the management company of these 2 entities, that in the absence of specific instructions can exercise the voting rights at its discretion.

Contact:
Nyxoah
David DeMartino, Chief Strategy Officer
[email protected]

Attachment

GlobeNewswire Distribution ID 1000964438

China’s ‘Chang’e 6’ lifts off with samples collected from lunar far side


BEIJING: China’s Chang’e 6 mission has completed the most important part of its lunar adventure as its sample-loaded ascender lifted off from the moon’s far side on Tuesday morning, China Daily reported.

The China National Space Administration initiated the ascent engine of the ascender, a key component of the Chang’e 6 robotic probe, at 7:38 am. Subsequently, it traversed for approximately six minutes before attaining lunar orbit.

The mission has collected lunar samples in the past two days, and they are sealed inside a container on the ascender.

The space administration said the ascender’s return to lunar orbit marked the successful completion of the first sampling and liftoff operations on the moon’s far side by any country.

The Chang’e 6 spacecraft, representing the world’s first attempt to bring samples from the lunar far side back to Earth, was launched by a “Long March 5” heavy-lift carrier rocket on 3rd May from the Wenchang Space Launch Centre in Hainan province. It entered lunar orbit on 8th May
.

Source: Emirates News Agency

FIRE BREAKS OUT BETWEEN SOUTHERN LEBANON’S AANQOUN AND KFARHATTA

A massive fire broke out in a valley between the southern Lebanese towns of Aanqoun and Kfarhatta in Al-Zahrani district, our correspondent in Zahrani reported on Tuesday.

Firefighting and civil defense teams duly arrived on scene in an attempt to control the blaze before it further spreads.

Source: National News Agency – Lebanon